| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |